Comprehensive Notes on Menstruation, Endometriosis, and Menopause

The Multi-Faceted Role of Estrogen

• Beyond Reproduction: Estrogen is often mistakenly viewed as a hormone strictly concerned with reproduction. However, it plays vital roles across various body systems:

  • Bone Density: Estrogen is essential for maintaining bone strength; it actively stimulates osteoblasts, the cells responsible for bone formation.

  • Energy Levels: It influences the body's overall energy and metabolism.

  • Cholesterol Regulation: It helps manage cholesterol levels in the blood.

  • Mood Stability: Fluctuations in estrogen are closely linked to mood changes and emotional regulation.

  • Body Temperature Regulation: Estrogen assists the hypothalamus in regulating the body's internal thermostat.

  • Cardiovascular Health: It plays a role in maintaining healthy blood pressure and overall cardiovascular function.

• Consequences of Depletion: When estrogen levels begin to drop, as seen in menopause, it leads to systemic issues like osteoporosis (bone thinning), hot flashes (thermoregulation failure), and increased cardiovascular risks.

Critical Thinking in Pathophysiology Study

• The "Why" Over Memorization: In clinical education, such as preparing for the NCLEX, students are encouraged not to simply memorize symptoms (e.g., "menopausal patients have hot flashes"). Instead, one must understand the underlying physiology.

• Correlative Learning: If you know that estrogen regulates temperature, it logically follows that a depletion of estrogen will cause temperature regulation issues (hot flashes). Understanding the "why" allows for critical thinking throughout a disease process rather than rote memorization.

Basic Menstrual Terminology and Clinical Presentations

• Menarche: The very first menstrual cycle.

  • Typical Age: Usually occurs between $10$ and $12\,years$ of age.

  • Recent Trends: Due to hormones present in the modern food supply, menarche can occur as early as $9$ or $10\,years$ old.

• Menstruation: The periodic discharge of blood and tissue from the uterus. This occurs from puberty until menopause, except during periods of pregnancy.

• Clinical Priority (The Pregnancy Test Rule): If a patient presents with a missed period (e.g., absent for $3\,months$), the absolute first diagnostic step is a pregnancy test. Practitioners must rule out pregnancy before investigating hormonal diseases or other pathologies.

• Amenorrhea: The absence of menstrual flow.

• Dysmenorrhea: Pain experienced during or shortly before menstruation.

• Menopause: The permanent cessation of menstruation.

Understanding Amenorrhea: Primary, Secondary, and Hypogonadotropic

• Clinical Warning Signs of Disorders:

  • The absence of both menarche and secondary sexual characteristics by age $14\,years$.

  • The absence of menses by age $15\,years$, regardless of whether the patient shows normal growth and development.

• Primary Amenorrhea: This refers to a situation where menstruation has never occurred.

• Secondary Amenorrhea: A period of $6\,months$ or more where menses are absent after the patient has already established a regular menstrual cycle. This indicates a secondary cause or lapse rather than an initial failure to start.

• Hypogonadotropic Amenorrhea:

  • Etiology: This is essentially a hypothalamic suppression of hormones triggered by stress.

  • Biological Mechanism: When the body is under extreme stress, it effectively decides "now is not a good time to be pregnant."

  • Common Causes: Highly strenuous exercise (athletes), extreme stress, and eating disorders such as anorexia.

  • Clinical Presentation: Periods may be skipped, erratic, or occur at long intervals (e.g., every $2\,months$).

Cyclic Perimenstrual Pain and Discomfort (CPPD)

• Definition: A cluster of symptoms including discomfort, dysmenorrhea, PMS, and PMDD that occurs before and after the start of menstrual flow.

• Premenstrual Syndrome (PMS): Includes symptoms such as mood swings, headaches, bloating, nausea, and dizziness.

• Premenstrual Dysphoric Disorder (PMDD): A severe, life-altering variant of PMS.

  • Impact: Can be so extreme that patients must miss work.

  • Management: May require treatment with antidepressants, physicians' intervention, or therapy.

  • Timing: Primarily a "pre-period" symptom profile.

Dysmenorrhea and Prostaglandin Physiology

• Mechanism of Pain: During the shedding of the endometrial lining, hormones called prostaglandins are released to induce uterine contractions (cramping) to help expel the tissue.

• Systemic Effects: Prostaglandins also affect the smooth muscle of the bowels surrounding the uterus, which frequently causes diarrhea during menstruation.

• Risk Factors for Increased Pain:

  • Obesity.

  • Smoking.

  • Limited physical activity.

  • Poor diet.

• Statistics: Approximately $75\%$ of women report discomfort, with $15\%$ reporting severe pain. It is most commonly reported in women aged $17$ to $24\,years$.

• Management Strategies:

  • NSAIDs: These are used specifically because they block prostaglandins, thereby reducing contractions and pain. Tylenol is less effective for this specific mechanism.

  • Oral Contraceptives: These prevent ovulation and keep the endometrial lining thin. Since there is less tissue to shed, the periods are lighter and less painful.

  • Caffeine: Often found in medications like Midol, caffeine provides an energy boost and helps treat associated headaches/migraines.

Alterations in Cyclic Bleeding Cycles

• Normal Cycle Parameters: The average cycle is $28\,days$, though a range of $20$ to $35\,days$ is considered normal depending on the individual.

• Oligomenorrhea: Infrequent menstrual periods occurring at intervals of $40$ to $45\,days$ or longer. Often linked to hypothalamic, pituitary, or ovarian dysfunction.

• Hypomenorrhea: Scanty or light bleeding occurring at normal intervals; can be associated with contraception or infection.

• Metrorrhagia: Any episode of bleeding (spotting or hemorrhage) that occurs at a time other than the normal period.

• Menorrhagia (Hypermenorrhea): Excessive menstrual bleeding in either duration or amount.

  • Pathophysiology: Often involves excessive tissue engorgement in the uterus leading to more shedding.

  • Treatments: Oral contraceptives, D&C (dilation and curettage), or endometrial ablation.

Endometriosis: Pathophysiology, Etiology, and Assessment

• Definition: A condition where endometrial cells (the tissue that usually lines the uterus) find a way outside the uterus and attach to other organs.

• The Problem of the "No Path Escape": Like the lining inside the uterus, these displaced cells respond to cyclic hormonal changes by swelling and bleeding. However, because they are outside the uterus, the blood has no path of escape. This leads to:

  • Inflammation.

  • Scar tissue formation.

  • Adhesions (internal tissues sticking together).

  • Cysts (sometimes filled with fluid or blood).

• Common Locations: Ovaries, intestines, fallopian tubes, and the outer uterine wall.

• Etiology and Risk Factors:

  • Retrograde Menstruation: Tissue moving through the tubes into the pelvic cavity.

  • Family History: Significant familial connection between mothers and daughters.

  • Menarche Timing: Higher risk if menarche occurred at age $11\,years$ or younger.

  • Parity: Higher risk for those who have never given birth (nulliparity).

  • Surgical Displacement: Procedures like C-sections can inadvertently displace endometrial cells to other parts of the body.

• Clinical Manifestations:

  • Severe dysmenorrhea (lower abdominal or pelvic pain).

  • Unilateral or bilateral pain that may radiate down the legs.

  • Pain during intercourse (Dyspareunia).

  • Lower back pain.

  • Infertility due to adhesions and scar tissue.

Diagnostic Procedures and Medical Management of Endometriosis

• Diagnostics:

  • Pelvic Exam: Initial assessment.

  • Ultrasound/MRI: Transvaginal ultrasound can be used. Some specialized MRIs can now grade endometriosis from level $1$ through $5$.

  • Laparoscopy: The "Gold Standard" for diagnosis. It involves surgical visualization to see the "endometrial spots."

• Medical Management:

  • Hormonal Therapies: Oral contraceptives to regulate/suppress the cycle.

  • FDA Approved Medication: Elagodilus (also known as Orlyza or Orlissa) specifically for moderate to severe endometriosis pain.

  • Surgical Options: Laparoscopy with laser ablation (cleaning up the spots) or radical surgeries like Hysterectomy (uterus removal), Oophorectomy (ovaries removal), and Salpingectomy (fallopian tube removal).

Menopause: Physiological Transition and Symptomatology

• Clinical Definition: A complete cessation of menses for a duration of one full year ($12\,months$).

• Physiological Changes:

  • Inovulation (failure to ovulate) occurs frequently.

  • Ovarian follicles become less sensitive to Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH).

  • FSH levels become elevated.

  • Progesterone is no longer produced by the corpus luteum.

• Physical Symptoms of Perimenopause:

  • Inconsistent, irregular periods.

  • Vaginal Atrophy: Decreased lubrication, making intercourse more difficult or painful.

  • Vasomotor Instability: Occurs in $75\%$ of women. This includes night sweats and hot flashes.

• The Hypothalamus and Hot Flashes:

  • When estrogen stops circulating, the hypothalamus (the brain's thermostat) becomes oversensitive.

  • It perceives the body's temperature incorrectly and sends a "hot flash" to attempt to regulate it.

• Other Risks: Post-menopausal women have a high risk for osteoporosis because the lack of estrogen stops the stimulation of osteoblasts.

Hormone Replacement Therapy (HRT)

• Purpose: To mitigate the symptoms of menopause by replacing lost hormones.

• Risks:

  • Breast cancer (hormones can act like "fertilizer" to certain cancer cells).

  • Heart disease.

• Side Effects:

  • Headaches and nausea.

  • Bloating and weight gain.

  • Brown skin spots.

• Routes of Administration: Tablets, topical creams, transdermal patches, suppositories, and vaginal creams.

Questions and Discussion

Femring Commercial Activity

• Product: Femring (a vaginal estrogen ring).

• Function: Used for vaginal dryness and hot flashes associated with menopause.

• Dosing: Available in two strengths: $0.05\,mg$ per day and $0.10\,mg$ per day.

• Duration: One ring releases estrogen over a period of $90\,days$.

• Application: Flexible and soft; the patient "squeezes, inserts, and goes."

• Side Effects: Breast tenderness/swelling, vaginal irritation, headache, nausea, and fluid detention.

• Warning Signs: Patients must monitor for signs of an allergic reaction (hives, difficulty breathing, swelling of face/lips) or symptoms of Toxic Shock Syndrome (TSS), which includes fever with nausea, vomiting, diarrhea, muscle pain, and dizziness.

• Cardiovascular Warnings: Patients were cautioned about the risk of Deep Vein Thrombosis (DVT), heart attack, and stroke when using hormonal products.